ATE505465T1 - Chroman- und thiochroman-3-yl-1,3- dihydroimidazole als hemmer der dopamin-beta- hydroxylase und verfahren zu ihrer herstellung - Google Patents
Chroman- und thiochroman-3-yl-1,3- dihydroimidazole als hemmer der dopamin-beta- hydroxylase und verfahren zu ihrer herstellungInfo
- Publication number
- ATE505465T1 ATE505465T1 AT07076125T AT07076125T ATE505465T1 AT E505465 T1 ATE505465 T1 AT E505465T1 AT 07076125 T AT07076125 T AT 07076125T AT 07076125 T AT07076125 T AT 07076125T AT E505465 T1 ATE505465 T1 AT E505465T1
- Authority
- AT
- Austria
- Prior art keywords
- thiochroman
- dihydroimidazole
- chroman
- hydroxylase
- inhibitors
- Prior art date
Links
- -1 CHROMAN- AND THIOCHROMAN-3-YL-1,3-DIHYDROIMIDAZOLE Chemical compound 0.000 title 1
- 108010015720 Dopamine beta-Hydroxylase Proteins 0.000 title 1
- 102100033156 Dopamine beta-hydroxylase Human genes 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0223719A GB2393958A (en) | 2002-10-11 | 2002-10-11 | Peripherally-selective imidazole inhibitors of dopamine-beta-hydroxylase |
| GB0224306A GB2394223B (en) | 2002-10-11 | 2002-10-18 | Peripherally-selective inhibitors of dopamine-beta-hydroxylase and method of their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE505465T1 true ATE505465T1 (de) | 2011-04-15 |
Family
ID=9945777
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07076125T ATE505465T1 (de) | 2002-10-11 | 2003-10-10 | Chroman- und thiochroman-3-yl-1,3- dihydroimidazole als hemmer der dopamin-beta- hydroxylase und verfahren zu ihrer herstellung |
| AT07076122T ATE500248T1 (de) | 2002-10-11 | 2003-10-10 | Silyl-geschützte hydroxymethyl-carbamoylalkyl- ketone als intermediate in der herstellung von dopamine-beta-hydroxylase inhibitoren |
| AT07076123T ATE550335T1 (de) | 2002-10-11 | 2003-10-10 | 3,4-dihydro-3-amino-2h-1-benzopyran und - benzothiopyran derivate als dopamine-beta- hydroxylase inhibitoren und verfahren zu ihrer herstellung |
| AT07076124T ATE500247T1 (de) | 2002-10-11 | 2003-10-10 | Verfahren zur herstellung von 3-(1,3- dihydroimidazol-2-thion-1-yl)-chromanen und thiochromanen als dopamin-beta-hydroxylase inhibitor |
| AT03256420T ATE403652T1 (de) | 2002-10-11 | 2003-10-10 | Imidazolderivate und deren verwendung als peripheral-selektive inhibitoren von dopamin-beta-hydroxylasen |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07076122T ATE500248T1 (de) | 2002-10-11 | 2003-10-10 | Silyl-geschützte hydroxymethyl-carbamoylalkyl- ketone als intermediate in der herstellung von dopamine-beta-hydroxylase inhibitoren |
| AT07076123T ATE550335T1 (de) | 2002-10-11 | 2003-10-10 | 3,4-dihydro-3-amino-2h-1-benzopyran und - benzothiopyran derivate als dopamine-beta- hydroxylase inhibitoren und verfahren zu ihrer herstellung |
| AT07076124T ATE500247T1 (de) | 2002-10-11 | 2003-10-10 | Verfahren zur herstellung von 3-(1,3- dihydroimidazol-2-thion-1-yl)-chromanen und thiochromanen als dopamin-beta-hydroxylase inhibitor |
| AT03256420T ATE403652T1 (de) | 2002-10-11 | 2003-10-10 | Imidazolderivate und deren verwendung als peripheral-selektive inhibitoren von dopamin-beta-hydroxylasen |
Country Status (11)
| Country | Link |
|---|---|
| KR (1) | KR101350741B1 (de) |
| CN (1) | CN100393715C (de) |
| AR (2) | AR041589A1 (de) |
| AT (5) | ATE505465T1 (de) |
| CY (2) | CY1108452T1 (de) |
| DE (4) | DE60336276D1 (de) |
| DK (2) | DK1908760T3 (de) |
| ES (5) | ES2309279T3 (de) |
| GB (2) | GB2393958A (de) |
| HK (1) | HK1116188A1 (de) |
| SI (2) | SI1908760T1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0708818D0 (en) * | 2007-05-08 | 2007-06-13 | Portela & Ca Sa | Compounds |
| BR112013015864B1 (pt) * | 2010-12-22 | 2021-11-09 | Bial - Portela & C.A., S.A. | Processo para purificar um composto de forma cristalina a de (r)-5-(2-benzilamino)etil)-1- (6,8-difluorocroman-3-il)-1h-imidazol-2(3h)-tiona |
| GB201316410D0 (en) * | 2013-09-13 | 2013-10-30 | Bial Portela & Ca Sa | Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2581556B2 (ja) * | 1986-05-06 | 1997-02-12 | メレルダウファーマスーティカルズ インコーポレーテッド | 新規なドパミンベ−タヒドロキシラ−ゼ抑制剤 |
| US4868210A (en) | 1988-03-30 | 1989-09-19 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| WO1995029165A2 (en) * | 1994-04-26 | 1995-11-02 | Syntex (U.S.A.) Inc. | Benzocycloalkylaz0lethione derivatives as dopamin beta-hydroxylase inhibitors |
-
2002
- 2002-10-11 GB GB0223719A patent/GB2393958A/en not_active Withdrawn
- 2002-10-18 GB GB0224306A patent/GB2394223B/en not_active Expired - Lifetime
-
2003
- 2003-10-10 DE DE60336276T patent/DE60336276D1/de not_active Expired - Lifetime
- 2003-10-10 SI SI200331986T patent/SI1908760T1/sl unknown
- 2003-10-10 DK DK07076125.9T patent/DK1908760T3/da active
- 2003-10-10 AT AT07076125T patent/ATE505465T1/de active
- 2003-10-10 AT AT07076122T patent/ATE500248T1/de not_active IP Right Cessation
- 2003-10-10 ES ES03256420T patent/ES2309279T3/es not_active Expired - Lifetime
- 2003-10-10 DE DE60336772T patent/DE60336772D1/de not_active Expired - Lifetime
- 2003-10-10 DK DK03256420T patent/DK1408038T3/da active
- 2003-10-10 AR ARP030103711A patent/AR041589A1/es active IP Right Grant
- 2003-10-10 SI SI200331309T patent/SI1408038T1/sl unknown
- 2003-10-10 ES ES07076123T patent/ES2384118T3/es not_active Expired - Lifetime
- 2003-10-10 ES ES07076124T patent/ES2361939T3/es not_active Expired - Lifetime
- 2003-10-10 DE DE60336275T patent/DE60336275D1/de not_active Expired - Lifetime
- 2003-10-10 AT AT07076123T patent/ATE550335T1/de active
- 2003-10-10 DE DE60322642T patent/DE60322642D1/de not_active Expired - Lifetime
- 2003-10-10 KR KR1020127005102A patent/KR101350741B1/ko active IP Right Grant
- 2003-10-10 AT AT07076124T patent/ATE500247T1/de not_active IP Right Cessation
- 2003-10-10 CN CNB2003801059426A patent/CN100393715C/zh not_active Expired - Fee Related
- 2003-10-10 AT AT03256420T patent/ATE403652T1/de active
- 2003-10-10 ES ES07076125T patent/ES2364919T3/es not_active Expired - Lifetime
- 2003-10-10 ES ES07076122T patent/ES2361938T3/es not_active Expired - Lifetime
-
2008
- 2008-10-09 HK HK08111214.9A patent/HK1116188A1/xx not_active IP Right Cessation
- 2008-10-24 CY CY20081101204T patent/CY1108452T1/el unknown
-
2011
- 2011-07-01 CY CY20111100639T patent/CY1112457T1/el unknown
-
2014
- 2014-03-18 AR ARP140101283A patent/AR095674A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE500247T1 (de) | 2011-03-15 |
| GB0224306D0 (en) | 2002-11-27 |
| ATE500248T1 (de) | 2011-03-15 |
| ES2364919T3 (es) | 2011-09-16 |
| SI1408038T1 (sl) | 2008-10-31 |
| ES2361939T3 (es) | 2011-06-24 |
| DK1908760T3 (da) | 2011-07-25 |
| DE60336276D1 (de) | 2011-04-14 |
| GB2393958A (en) | 2004-04-14 |
| DK1408038T3 (da) | 2008-11-24 |
| KR20120038014A (ko) | 2012-04-20 |
| GB2394223B (en) | 2007-05-16 |
| AR041589A1 (es) | 2005-05-26 |
| CN1726211A (zh) | 2006-01-25 |
| ES2361938T3 (es) | 2011-06-24 |
| AR095674A2 (es) | 2015-11-04 |
| GB0223719D0 (en) | 2002-11-20 |
| HK1116188A1 (en) | 2008-12-19 |
| KR101350741B1 (ko) | 2014-01-10 |
| DE60322642D1 (de) | 2008-09-18 |
| ES2384118T3 (es) | 2012-06-29 |
| CY1108452T1 (el) | 2014-04-09 |
| CN100393715C (zh) | 2008-06-11 |
| GB2394223A (en) | 2004-04-21 |
| DE60336772D1 (de) | 2011-05-26 |
| ES2309279T3 (es) | 2008-12-16 |
| DE60336275D1 (de) | 2011-04-14 |
| ATE550335T1 (de) | 2012-04-15 |
| CY1112457T1 (el) | 2015-12-09 |
| ATE403652T1 (de) | 2008-08-15 |
| SI1908760T1 (sl) | 2011-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60324376D1 (de) | Halbleiterbauelement und Verfahren zu dessen Herstellung | |
| DE60335802D1 (de) | Fass und verfahren zu seiner herstellung | |
| DE602004021927D1 (de) | Halbleiterbauelement und verfahren zu seiner herstellung | |
| DE60325690D1 (de) | Halbleiterbauelement und verfahren zu seiner herstellung | |
| DE60313602D1 (de) | N-iPHENYL(PIPERIDIN-2-YL)METHYLöBENZAMIDDERIVATE,VERFAHREN ZU IHRER HERSTELLUNG UND IHRE THERAPEUTISCHE ANWENDUNG | |
| DE60334183D1 (de) | Faserplatte und Verfahren zu ihrer Herstellung | |
| DE502004002403D1 (de) | Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer | |
| ATE419260T1 (de) | C-aryl-glucosid-sglt2-inhibitoren und verfahren zu ihrer herstellung | |
| DE60337036D1 (de) | Halbleiterbauelement und verfahren zu seiner herstellung | |
| DE602004015020D1 (de) | Harzverkapselter elektronischer Bauteil und Verfahren zu seiner Herstellung | |
| DE602004002122D1 (de) | Doppelrohr und Verfahren zu dessen Herstellung | |
| DE502006009351D1 (de) | Feinteiliges azopigment und verfahren zu seiner herstellung | |
| DE502004002117D1 (de) | Substituierte thiazol-benzoisothiazoldioxidderivative, verfahren zu deren herstellung und deren verwendung | |
| DK1626964T3 (da) | Nye benzimidazolderivater | |
| DE602005013692D1 (de) | Halbleiterbauelement und verfahren zu seiner herstellung | |
| DE60335812D1 (de) | Biosensor und verfahren zu seiner herstellung | |
| DE60313797D1 (de) | Halbleiter-Lichtemissionsbauelement und Verfahren zu seiner Herstellung | |
| DE60332463D1 (de) | Hochbrillianter mechanolumineszenzstoff und verfahren zu seiner herstellung | |
| ATE543896T1 (de) | Granulat als zusatz zu reinigungsmittel und verfahren zu seiner herstellung | |
| DE112005002085A5 (de) | Zerspanungswerkzeug und Verfahren zu seiner Herstellung | |
| ATE440821T1 (de) | Isochinolinderivate als mao-b inhibitoren | |
| DE60233077D1 (de) | Halbleiterbauelement und verfahren zu seiner herstellung | |
| DE60327412D1 (de) | Kreisförmiger Metallgegenstand und Verfahren zu dessen Herstellung | |
| DE60316383D1 (de) | Aminzusammensetzung und Verfahren zu ihrer Herstellung | |
| DE602004003459D1 (de) | Optischer Halbleiter und Verfahren zu seiner Herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1908760 Country of ref document: EP |